Project scope

To optimally launch SCD products in GCC markets through understanding price potential and feasibility of innovative contracting in order to boost patient access

Challenge

Our client is a leading innovator committed to developing treatments for patients with sickle cell anaemia and wanted to understand how to optimally launch in GCC markets through understanding price potential and feasibility of innovative contracting in order to boost patient access

Solution

Extensive secondary research into core markets and primary research:

• In-depth secondary research was conducted focusing on understanding the prevalence of SCD, patient journey and competitor products
• Conducted primary research consisting of qualitative and quantitative discussions to understand the nuances within the SCD landscape across key geographies alongside testing the price and access potential for a SCD drug

Results

Successfully enabled our client to understand achievable price and access schemes feasible across each market